Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-803405
Filing Date
2016-12-27
Accepted
2016-12-27 06:20:02
Documents
7
Period of Report
2016-12-27

Document Format Files

Seq Description Document Type Size
1 6-K d218312d6k.htm 6-K 13583
2 EX-99.1 d218312dex991.htm EX-99.1 32980
3 EX-99.2 d218312dex992.htm EX-99.2 17061
4 GRAPHIC g218312ex991logo1.jpg GRAPHIC 10737
5 GRAPHIC g218312ex991logo2.jpg GRAPHIC 2699
6 GRAPHIC g218312ex992logo1.jpg GRAPHIC 11165
7 GRAPHIC g218312ex992logo2.jpg GRAPHIC 12583
  Complete submission text file 0001193125-16-803405.txt   116582
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 162069633
SIC: 2834 Pharmaceutical Preparations